Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05205616 · ClinicalTrials.gov registry record · NA

Trial of Bilateral Sagittal Split Osteotomy Induced Paresthesia Using Ultrasonic vs. Reciprocating Saw Instrumentation

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT05205616 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05205616, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The aim of this prospective study is to analyze the postoperative paresthesias experienced in patients who undergo bilateral sagittal split osteotomies (BSSO) using an ultrasonic saw, versus a reciprocating saw. Patients included in the study are ages 15-45 scheduled to undergo BSSO surgery at the University of California, San Francisco. One side of the patient's mandible will be instrumented with either the Stryker Sonopet ultrasonic saw or traditional reciprocating saw, while the other side will receive the remaining intervention (determined via randomization on the day of surgery). Patient paresthesias will then be analyzed on each side for 3 months postoperatively (at postoperative days: 1, 7, 14, 28, and 84). Sensory examinations will be carried out by blinded examiners using von Frey hairs and two point discrimination testing. Patients will also subjectively rate their sensation on each side. The results will then be analyzed to determine if patient paresthesias, including the severity and duration, differed depending on which instrument was used, the ultrasonic or reciprocating saw.

Interventions

  • DEVICE Sonopet ultrasonic saw
  • DEVICE Reciprocating saw

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2021-07-20
Est. Completion 2023-07-25
Phase NA

What the Registry Record Tells You About NCT05205616

The ClinicalTrials.gov registry entry for NCT05205616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sonopet ultrasonic saw is the first listed.

NCT05205616 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05205616 about?

NCT05205616 is a clinical study titled "Trial of Bilateral Sagittal Split Osteotomy Induced Paresthesia Using Ultrasonic vs. Reciprocating Saw Instrumentation". The aim of this prospective study is to analyze the postoperative paresthesias experienced in patients who undergo bilateral sagittal split osteotomies (BSSO) using an ultrasonic saw, versus a reciprocating saw. Patients included in the study are ages 15-45 scheduled to undergo BSSO surgery at the U...

What is the current status of trial NCT05205616?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2021-07-20. Estimated completion is 2023-07-25.

What interventions are being tested in trial NCT05205616?

The interventions under investigation include: Sonopet ultrasonic saw (DEVICE), Reciprocating saw (DEVICE).

Who is sponsoring clinical trial NCT05205616?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.